On March 15, the 17th China Industry-Academic-Research Cooperation and Innovation Conference was grandly held in Beijing. The “Establishment and Clinical Application of a Precision Treatment System for Gastrointestinal Stromal Tumors” project led by Professor Tao Kaixiong’s team from the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology and participated by Wuhan Half the Sky Medical Technology Development Co., Ltd. won the first prize of the 2025 China Industry-Academic-Research Cooperation Innovation Achievement Award.
This honor is not only a high recognition of the scientific research strength of the project team, but also fully demonstrates Wuhan Half the Sky’s deep accumulation and collaborative innovation capabilities in the field of minimally invasive medical devices, injecting strong momentum into the construction of a precise diagnosis and treatment system for gastrointestinal tumors in my country.
Collaborate between industry, academia and research to create an innovative highland
As an important benchmark for measuring the effectiveness of my country’s industry-university-research collaboration, the “China Association for the Promotion of Industry-University-Research Cooperation Science and Technology Innovation Award” has always had strict evaluation standards. The current review committee is composed of authoritative experts in relevant fields. It conducts a fair, impartial and open comprehensive evaluation of the submitted projects based on multiple dimensions such as technological innovation, clinical practical value, achievement transformation ability and social benefits.
The “Establishment and Clinical Application of a Precision Treatment System for Gastrointestinal Stromal Tumors” project was highly recognized by the review team for its technological breakthrough in solving the difficulties in the diagnosis and treatment of gastrointestinal stromal tumors and its remarkable efficacy in clinical application. The project’s successful award is a strong affirmation of Professor Tao Kaixiong’s team and Wuhan Half the Sky’s insistence on joint research “based on clinical needs” for many years.
In-depth integration of medicine and industry to promote technology implementation
As an important partner of this project, Wuhan Half the Sky has long been engaged in the research and development and innovation of radiofrequency and ultrasound composite energy surgical systems. It has an independent research and development team and a number of domestic and foreign patented technologies, providing solid technical support and industrialization guarantee for the implementation of the project.
In-depth collaboration between doctors and engineers to solve clinical pain points: In-depth collaboration between doctors and engineers turned clinical pain points during surgery into research and development topics, developed high-precision surgical instruments suitable for gastrointestinal stromal tumor surgery, and successfully solved key technical bottlenecks in this field.
Promote the transformation of results and accelerate the implementation of technology: relying on Wuhan Half the Sky’s mature manufacturing system, it has efficiently realized the transformation from laboratory innovation to clinical products, benefiting the majority of gastrointestinal stromal tumor patients.
Leading technology iteration and boosting domestic upgrading: Through the clinical application of the project, Wuhan Half the Sky has further verified the excellent performance of the composite energy platform in complex open and laparoscopic surgeries, effectively promoting the popularization and application of domestic high-end medical devices in the field of gastrointestinal surgery.
Based on a new starting point, continue to write a new chapter in the medical industry
This award is an important milestone for Wuhan Half the Sky to deepen the integration of medicine and industry and move towards high-quality development.
Wuhan Half the Sky will take this as a starting point, and under the leadership of General Manager Qiu Xuewen, continue to focus on the cutting-edge technology of minimally invasive surgery, adhere to the full-cycle health concept of “prevention, diagnosis, treatment, and rehabilitation”, continue to increase investment in research and development, promote more innovative results to take root, provide clinicians with more stable, reliable, and efficient surgical solutions, and let Half the Sky’s minimally invasive technology benefit global life and health!